back to portfolio︁
Berkeley Lights completed its IPO in 2020 and has established market leadership in digital cell biology.
Berkeley Lights Inc is a digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products.
Exited
MANAGEMENT TEAM
Eric Hobbs
Keith Breinlinger
INVESTMENT TEAM
Lip-Bu Tan
Michael Marks
Nicholas Brathwaite
Sarah Lucas
Category
Life Sciences
HealthTech
HQ
USA
Berkeley Lights
in the News
Berkeley Lights and TPG Biologics Enter into a Strategic Collaboration for Cell Line Development - News Press Release | PharmiWeb.com
MD Anderson and Berkeley Lights launch Optera Therapeutics to accelerate development of cell therapy
Related Portfolio
